This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Myongji University Industry and Academia Cooperation Foundation, University of Illinois. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 53 
1 out of 2,424 
Years Active: 2015
Title: Innovations of Ying Yu Jin in Anti-Tuberculosis Research
Introduction
Ying Yu Jin is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of anti-Tuberculosis research. His work focuses on developing novel therapeutic agents to combat mycobacterial infections.
Latest Patents
Ying Yu Jin holds a patent related to anti-TB cyclic peptides derived from the strain MJM5123. The invention encompasses a process for producing these peptides and a pharmaceutical composition aimed at preventing and treating tuberculosis. This composition demonstrates high activity against both replicating and non-replicating strains, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. It is positioned as an effective therapeutic agent for tuberculosis.
Career Highlights
Throughout his career, Ying Yu Jin has been associated with prestigious institutions such as the University of Illinois and Myongji University Industry and Academia Cooperation Foundation. His work in these organizations has furthered research and development in the field of infectious diseases.
Collaborations
Ying Yu Jin has collaborated with notable colleagues, including Sanghyun Cho and Guido F Pauli. These partnerships have contributed to the advancement of his research and the development of innovative solutions in combating tuberculosis.
Conclusion
Ying Yu Jin's contributions to anti-Tuberculosis research highlight his commitment to addressing critical health challenges. His innovative approaches and collaborations have the potential to significantly impact the treatment of mycobacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile